Samumed Receives Orphan Drug Designation from FDA for SM04646
Samumed announced that the U.S. FDA has granted SM04646, a novel small molecule Wnt pathway inhibitor, an Orphan Drug Designation (ODD) for IPF: http://bit.ly/2gStpOf...
Is 2017 set to be the year we see a CAR-T therapy approved? Let’s find out from the leaders in the field
Using your body’s own cells, engineering them to target tumors and cure cancer sounds like something from a Sci-Fi movie but it’s not, it’s...
AMO Pharma Enters into Development and License Agreement with Numedicus ltd
AMO Pharma Limited , a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, announced it has entered into...
DelMar Pharmaceuticals Receives IRB Approval for Pivotal Phase 3 Clinical Trial of VAL-083
DelMar Pharmaceuticals , a biopharmaceutical company focused on the development of new cancer therapies, announced it has received Institutional Review Board (IRB) approval to...
FierceBiotech’sDrug Development Forum Attracts Executive-Level Biopharma Professionals for Second Annual Conference in Boston This September
Attendees of FierceBiotech’s 2ndAnnual Drug Development Forum will obtain essential funding strategies and more productive R&D through executive-level networking opportunities. Convening at the Renaissance...
FDA chooses Zepsyre from PharmaMar to explore potential development for pediatric cancers
The Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) of the FDA, has invited PharmaMar to participate in this ODAC, giving a presentation to...
Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti
Evoke Pharma Inc , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases announced that it has entered into an agreement with...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...